FDA Warning Letter — BP

Case 515932 — FEI 3013182312

The FDA took a Warning Letter action against BP on Jan 26, 2017 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Jan 26, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.